Barbara I Gulanski MD
Diabetes, Lipid Metabolism
Associate Professor, Internal Medicine, Yale University School of Medicine
Join to view full profile
789 Howard Avenue 2nd FloorDana BuildingNew Haven, CT 06519
Dr. Gulanski is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1990
Temple University HospitalResidency, Internal Medicine, 1982 - 1985
New York University School of MedicineClass of 1982
Certifications & Licensure
NJ State Medical License 1986 - Present
CT State Medical License 1988 - 2027
PA State Medical License 1984 - 1988
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Clinical Trials
- Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis Start of enrollment: 2000 Oct 01
- Impact of Diet and/or Exercise-induced Weight Loss on Cardiovascular Risk Factors Start of enrollment: 2003 Aug 01
- C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
Publications & Presentations
PubMed
- Reversible alterations of brain acetate metabolism associated with alcohol consumption.Chathura Kumaragamage, Lihong Jiang, Gustavo A Angarita, Robin A de Graaf, Elizabeth Guidone
Neuropsychopharmacology. 2026-09-01 - Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.Kasia J Lipska, Kelson Zawack, Lei Yan, Pradeep Mutalik, Jingmao Li
Annals of Internal Medicine. 2026-08-01 - Timing of Denosumab Therapy in Relation to Parathyroidectomy in the Setting of Primary Hyperparathyroidism: Case Report.Ryan S MacLeod, Adriana Ramirez, Barbara Gulanski, Sachin K Majumdar
Case Reports in Endocrinology. 2026-01-01
Press Mentions
Can GLP-1s Help People Stop Insulin?August 13th, 2026
Grant Support
- Longitudinal Impact Of Weight Loss On Metabolic Markers Of Cardiovascular RiskNational Center For Research Resources2005
- Gender Differences Of Undiagnosed Diabetes In Acute Coronary SyndromesNational Center For Research Resources2005
- C-Reactive Protein And Endothelial Dysfunction In Women With Glucose IntoleranceNational Center For Research Resources2005
- Impact Of Diet &Exercise On Metabolic Markers Of CV RisNational Center For Research Resources2004
- Gender Differences In Prevalence Of Undiagnosed DiabetesNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
